Analysts Say These 2 ‘Strong Buy’ Stocks Are Their Top Picks for 2023 [Yahoo! Finance News]
Arvinas, Inc. (ARVN)
Last arvinas, inc. earnings: 11/4 05:00 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance News
As the year winds toward its close, it’s time once again to engage in the age-old practice of picking out the changes that lie waiting in the year ahead. Wall Street’s stock pros are hardly immune from this; every year, they tag their top picks from the equity markets for the calendar change, and this year is no exception. The analysts are looking ahead toward the post-New Year market landscape, and picking out potential winners for investors to consider.We've opened up thedatabase at TipRanks89bio, Inc.(We’ll start with a clinical-stage biopharma company, 89bio. This firm has focused its research on severe, chronic, disease conditions affecting the liver and heart, specifically non-alcoholic steatohepatitis, or NASH, a serious liver disease, and hypertriglyceridemia, or SHTG, a cardio-metabolic disorder.89bio currently has just the one drug candidate, pegozafermin, which is the subject of two clinical trial research programs, one on each of these conditions.The company has announced
Show less
Read more
Impact Snapshot
Event Time:
ARVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARVN alerts
High impacting Arvinas, Inc. news events
Weekly update
A roundup of the hottest topics
ARVN
News
- Arvinas, Inc. (NASDAQ: ARVN) had its price target lowered by analysts at HC Wainwright from $90.00 to $87.00. They now have a "buy" rating on the stock.MarketBeat
- Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation [Seeking Alpha]Seeking Alpha
- Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised [Yahoo! Finance]Yahoo! Finance
- UPDATE 1-Novartis licenses Arvinas' cancer drug for up to $1 billion [Yahoo! Finance]Yahoo! Finance
- Novartis licenses Arvinas' cancer drug for up to $1 billion [Yahoo! Finance]Yahoo! Finance
ARVN
Earnings
- 2/27/24 - Miss
ARVN
Sec Filings
- 4/17/24 - Form ARS
- 4/16/24 - Form DEFA14A
- 4/16/24 - Form DEF
- ARVN's page on the SEC website